REQUEST A DEMO
Total
USD $0.00
Search more companies

U-Neuron Biomedical Inc. (Taiwan, China)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: U-Neuron Biomedical Inc. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

U-Neuron Biomedical Inc. is an enterprise located in Taiwan, China, with the main office in New Taipei City. The company operates in the Biological Product (except Diagnostic) Manufacturing sector. The company was established on April 03, 2026. In its most recent financial highlights, the company reported a net sales revenue increase of 92.71% in Q2C2025. Its’ total assets recorded a growth of 59.72%. The net profit margin of U-Neuron Biomedical Inc. increased by 96.92% in 2025.

Headquarters
18F-5,No.99, Sec.1,Xintai 5Th Rd, Xizhi Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the U-Neuron Biomedical Inc. report to view the information.

Website: http://www.u-neuron.com

Basic Information
Outstanding Shares:
Purchase the U-Neuron Biomedical Inc. report to view the information.
Financial Auditors:
Purchase the U-Neuron Biomedical Inc. report to view the information.
Incorporation Date:
April 03, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
14.23%
Purchase this report to view the information.
10.04%
Purchase this report to view the information.
2.53%
Purchase this report to view the information.
2.28%
Purchase this report to view the information.
2.15%
Subsidiaries
永艾芙生醫有限公司
100%
Company Performance
Financial values in the chart are available after U-Neuron Biomedical Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
92.71%
Total Operating Revenue
91.22%
Operating Profit
20.56%
EBITDA
27.81%
Net Profit/Loss for the Period
27.41%
Total Assets
59.72%
Total Equity
61.62%
Operating Profit Margin
100.68%
Net Profit Margin
96.92%
Return on Equity (ROE)
3.87%
Debt / Equity
855%
Quick Ratio
11208.12%
Cash Ratio
4.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?